Infrapatellar Fat Pad Preservation Versus Resection on Clinical Outcomes After Total Knee Arthroplasty(IPAKA) (IPAKA)
Primary Purpose
Knee Osteoarthritis, Arthropathy of Knee
Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Infrapatellar Fat Pad preservation
Infrapatellar Fat Pad resection
Sponsored by
About this trial
This is an interventional treatment trial for Knee Osteoarthritis focused on measuring Infrapatellar Fat Pad, Knee Osteoarthritis, Total Knee Arthroplasty, Randomized Clinical Trial
Eligibility Criteria
Inclusion Criteria:
- Participants diagnosed with knee osteoarthritis by X-ray plain film (Kellgren-Lawrence score of ≥ 2)
- The need for TKA was confirmed after evaluation by the orthopedic surgeon
- One week before surgery, knee pain 100mm pain visual analogue scale score was greater than 20mm
- Understanding of the study requirements and willing to participate in this study
Exclusion Criteria:
- Rheumatoid arthritis,psoriatic arthritis,lupus,malignant tumor
- Requiring contralateral TKA within one year
- The visual analogue score of 100mm of knee pain before operation was less than 20mm
- Having a possible or planned pregnancy
- With poor compliance
- Suffering from somatic disease, psychiatric or cognitive disorders, neurological disorders that will compromise the safety, compliance, consent, participation, follow-up and the interpretation of the results
- Severe knee valgus
- Contraindications with TKA or MRI
Sites / Locations
- Zhujiang HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Infrapatellar Fat Pad Preservation
Infrapatellar Fat Pad Resection
Arm Description
The IPFP retention of more than 80% in actual operation shall be regarded as IPFP retention.
In the clinical practice, more than 80% of IPFP volume is commonly resected by surgeons during total knee arthroplasty. The investigators hereby define resection of more than 80% IPFP volume as IPFP excision.
Outcomes
Primary Outcome Measures
The total score of Knee Injury and Osteoarthritis Outcome Score(KOOS)
The KOOS is a knee-specific patient-reported questionnaire with 42-items in five separately analysed subscales of pain, other symptoms, function in daily living, function in sport and recreation, and knee-related quality of life. Scores are transformed to a 0-100 scale, with 0 representing extreme knee problems and 100 representing no problems.
The functional subscale score of Knee Injury and Osteoarthritis Outcome Score(KOOS)
KOOS functional subscale score including function in daily living and function in sport and recreation. Scores range from 0 (worst) to 100 (best).
Secondary Outcome Measures
Other subscales of Knee Injury and Osteoarthritis Outcome Score (KOOS)
KOOS subscales including pain, symptoms and quality of life. Scores are transformed to a 0-100 scale, with 0 representing worst health and 100 representing best health.
Knee Society Score(KSS)
KSS is a rating system that consists of two scores: joint score and functional score. Both scores range from 0 (worst health or functioning) to 100 (best health or functioning).
Self-reported efficacy of reduced pain and increased quality of life
Using a 100mm VAS with terminal descriptors of "very unsure" and "very sure"
Insall - Salvati Ratio (ISR)
It is used to assess changes in the length of the patellar tendon at baseline and month 12. Lateral radiographs with the knee in about 30 degree of flexion will be taken by well experienced X-ray technicians using standardized radiographic techniques. The numerator of the ISR-the length of the patellar tendon-was determined by measuring the distance from inferior aspect of the patella to the superior aspect of the tibial tubercle. The longest dimension of the patella on the lateral radiograph will be obtained as denominator of the ISR.
Timed Up and Go test
It is a simple test used to assess a person's mobility. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.
Visual Analogue Scale (VAS) Pain
Pain intensity measured on a 100 mm VAS with terminal descriptors of "no pain" and "worst pain possible" in the following situations: at rest, after 30-min of walking, and on most days of the last month.
Full Information
NCT ID
NCT03763448
First Posted
October 19, 2018
Last Updated
November 4, 2022
Sponsor
Zhujiang Hospital
Collaborators
Peking Union Medical College Hospital, Peking University People's Hospital, Xiangya Hospital of Central South University, The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital of Jinan University, Anhui Provincial Hospital, Tianjin Hospital, Affiliated Hospital of Youjiang Medical University for Nationalities
1. Study Identification
Unique Protocol Identification Number
NCT03763448
Brief Title
Infrapatellar Fat Pad Preservation Versus Resection on Clinical Outcomes After Total Knee Arthroplasty(IPAKA)
Acronym
IPAKA
Official Title
Effects of Infrapatellar Fat Pad Preservation Versus Resection on Clinical Outcomes After Total Knee Arthroplasty in Patients With Knee Osteoarthritis - A Multicenter Randomized Controlled Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
December 17, 2018 (Actual)
Primary Completion Date
December 2022 (Anticipated)
Study Completion Date
December 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Zhujiang Hospital
Collaborators
Peking Union Medical College Hospital, Peking University People's Hospital, Xiangya Hospital of Central South University, The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital of Jinan University, Anhui Provincial Hospital, Tianjin Hospital, Affiliated Hospital of Youjiang Medical University for Nationalities
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
This study aims to compare the postoperative clinical outcomes of Infrapatellar Fat Pad (IPFP) preservation versus resection after total knee arthroplasty (TKA) in patients with knee osteoarthritis. Participants will be identified as normal IPFP or abnormal IPFP based on MRI findings before randomization. The primary outcome is the summed score of Knee Injury and Osteoarthritis Outcome Score (KOOS) covering pain, symptoms, activities of daily life, sport & recreation, knee-related quality of life, and KOOS subscale assessing activities of daily life, sport & recreation. The secondary endpoints will be included: KOOS subscales (pain, symptoms and quality of life), Knee Society Score (KSS), 100 mm Visual Analogue Scale (VAS) Pain, timed up-and-go test, depression, patellar tendon shortening, 100 mm VAS self-reported efficacy of reduced pain and increased quality of life. Adverse events will be recorded. Primary and secondary outcomes will be evaluated or reported blindly at baseline and at postoperative 3 months, 6 months, and 1 year. Intention-to-treat analyses will be used.
Detailed Description
Knee Osteoarthritis (KOA) is a common chronic disease, which often leads to joint pain and limited function in the elderly, and thus affects participants' quality of life. Total knee arthroplasty (TKA) has been developed as a mature surgical procedure to relieve end-stage osteoarthritic joint pain and improve limb function. Although more than 80% of the patients reported in the literature are satisfied with the postoperative efficacy of TKA, there are still a large number of patients whose daily life is affected by persistent knee pain and limited function after the operation of the affected limb.
The IPFP is a fat mass located behind the patellar ligament, between the lower part of the patella and the tibial tubercle. The function of IPFP is controversial at present. It is reported that IPFP can provide blood supply for anterior cruciate ligament, patella and patellar ligament through the arterial network of the knee joint. In addition, it can fill the joint gap to lubricate the surface of the joint, reduce friction and absorb impulse so as to play a physiological protective role. On the contrary, studies have pointed out that abnormal IPFP could produce various pro-inflammatory cytokines such as interleukin (IL)-1β, tumour necrosis factor (TNF)-α, IL-6 and IL-8, as well as adipokines such as leptin and resistin, and thus might play a detrimental role in knee OA. Traditionally, the IPFP has been removed in order to improve surgical exposure and to prevent interposition during baseplate implantation. Despite the significant evolution of TKA technology which no longer requires the resection of IPFP for better surgical access, IPFP is still partially or totally resected in around 88% of TKAs.
The investigators' previous population-based cohort study revealed that IPFP maximal area and volume were associated with reduced knee pain, decreased loss of cartilage volume and reduced risks of cartilage defect progression, indicating a beneficial effect of IPFP size. On the other hand, the investigators' further investigation demonstrated that IPFP signal intensity alteration was negatively associated with maximum area of IPFP, and moreover, associated with increased knee cartilage defects, subchondral bone marrow lesion (BML) and knee pain, suggesting IPFP with abnormal quality may play a detrimental role in knee OA. Based on these findings, the investigators proposed that IPFP with normal quality should be preserved or not damaged during TKA, while IPFP with abnormal quality should be resected. This multicentre randomised controlled trial is designed to test the investigators' hypotheses: in patients with normal IPFP quality, preservation of IPFP during TKA procedure will reduce postoperative knee symptoms and improve joint function, comparing with IPFP resection during TKA procedures; in patients with abnormal IPFP quality, resection of IPFP during TKA procedure will reduce postoperative knee symptoms and improve joint function, comparing with IPFP preservation during TKA procedures. The results would provide evidence-based recommendations on clinical practice to improve OA patients' postoperative outcomes.
Three hundred and sixty eligible participants will be recruited and identified as having normal IPFP quality (signal intensity alteration score ≤ 1) or abnormal IPFP quality (signal intensity alteration score ≥ 2). Participants in each site will be randomly allocated to IPFP resection group or preservation group using computer-generated block randomisation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis, Arthropathy of Knee
Keywords
Infrapatellar Fat Pad, Knee Osteoarthritis, Total Knee Arthroplasty, Randomized Clinical Trial
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
participants, outcome assessors, data analysts and chief investigators are masked during the study procedure.
Allocation
Randomized
Enrollment
360 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Infrapatellar Fat Pad Preservation
Arm Type
Experimental
Arm Description
The IPFP retention of more than 80% in actual operation shall be regarded as IPFP retention.
Arm Title
Infrapatellar Fat Pad Resection
Arm Type
Active Comparator
Arm Description
In the clinical practice, more than 80% of IPFP volume is commonly resected by surgeons during total knee arthroplasty. The investigators hereby define resection of more than 80% IPFP volume as IPFP excision.
Intervention Type
Procedure
Intervention Name(s)
Infrapatellar Fat Pad preservation
Other Intervention Name(s)
Infrapatellar fat pad retention
Intervention Description
In the IPFP preservation group, IPFP (more than 80%) will be preserved by retracting out of the operative field.
Intervention Type
Procedure
Intervention Name(s)
Infrapatellar Fat Pad resection
Intervention Description
In the IPFP resection group, more than 80% IPFP will be resected during the total knee arthroplasty.
Primary Outcome Measure Information:
Title
The total score of Knee Injury and Osteoarthritis Outcome Score(KOOS)
Description
The KOOS is a knee-specific patient-reported questionnaire with 42-items in five separately analysed subscales of pain, other symptoms, function in daily living, function in sport and recreation, and knee-related quality of life. Scores are transformed to a 0-100 scale, with 0 representing extreme knee problems and 100 representing no problems.
Time Frame
From pre-operation to 12 months after operation
Title
The functional subscale score of Knee Injury and Osteoarthritis Outcome Score(KOOS)
Description
KOOS functional subscale score including function in daily living and function in sport and recreation. Scores range from 0 (worst) to 100 (best).
Time Frame
From pre-operation to 12 months after operation
Secondary Outcome Measure Information:
Title
Other subscales of Knee Injury and Osteoarthritis Outcome Score (KOOS)
Description
KOOS subscales including pain, symptoms and quality of life. Scores are transformed to a 0-100 scale, with 0 representing worst health and 100 representing best health.
Time Frame
From pre-operation to 12 months after operation
Title
Knee Society Score(KSS)
Description
KSS is a rating system that consists of two scores: joint score and functional score. Both scores range from 0 (worst health or functioning) to 100 (best health or functioning).
Time Frame
From pre-operation to 12 months after operation
Title
Self-reported efficacy of reduced pain and increased quality of life
Description
Using a 100mm VAS with terminal descriptors of "very unsure" and "very sure"
Time Frame
From pre-operation to 12 months after operation
Title
Insall - Salvati Ratio (ISR)
Description
It is used to assess changes in the length of the patellar tendon at baseline and month 12. Lateral radiographs with the knee in about 30 degree of flexion will be taken by well experienced X-ray technicians using standardized radiographic techniques. The numerator of the ISR-the length of the patellar tendon-was determined by measuring the distance from inferior aspect of the patella to the superior aspect of the tibial tubercle. The longest dimension of the patella on the lateral radiograph will be obtained as denominator of the ISR.
Time Frame
From pre-operation to 12 months after operation
Title
Timed Up and Go test
Description
It is a simple test used to assess a person's mobility. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.
Time Frame
From pre-operation to 12 months after operation
Title
Visual Analogue Scale (VAS) Pain
Description
Pain intensity measured on a 100 mm VAS with terminal descriptors of "no pain" and "worst pain possible" in the following situations: at rest, after 30-min of walking, and on most days of the last month.
Time Frame
From pre-operation to 12 months after operation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Participants diagnosed with knee osteoarthritis by X-ray plain film (Kellgren-Lawrence score of ≥ 2)
The need for TKA was confirmed after evaluation by the orthopedic surgeon
One week before surgery, knee pain 100mm pain visual analogue scale score was greater than 20mm
Understanding of the study requirements and willing to participate in this study
Exclusion Criteria:
Rheumatoid arthritis,psoriatic arthritis,lupus,malignant tumor
Requiring contralateral TKA within one year
The visual analogue score of 100mm of knee pain before operation was less than 20mm
Having a possible or planned pregnancy
With poor compliance
Suffering from somatic disease, psychiatric or cognitive disorders, neurological disorders that will compromise the safety, compliance, consent, participation, follow-up and the interpretation of the results
Severe knee valgus
Contraindications with TKA or MRI
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Weiyu Han, MD
Phone
+86-13922222718
Email
hanweiyu@live.com
First Name & Middle Initial & Last Name or Official Title & Degree
Youling Xu, RN
Phone
+86-18210623686
Email
xuyoulinghao@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Changhai Ding, MD
Organizational Affiliation
Clinical Research Center of Zhujiang Hospital,Southern Medical University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jianhao Lin, MD
Organizational Affiliation
Peking University People's Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Xisheng Weng, MD
Organizational Affiliation
Peking Union Medical College Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Guanghua Lei, MD
Organizational Affiliation
Xiangya Hospital of Central South University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Zongsheng Yin, MD
Organizational Affiliation
The First Affiliated Hospital of Anhui Medical University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Zhengang Zha, MD
Organizational Affiliation
First Affiliated Hospital of Jinan University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jing Tian, MD
Organizational Affiliation
Zhujiang Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Xifu Shang, MD
Organizational Affiliation
Anhui Provincial Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Yujin Tang, MD
Organizational Affiliation
Affiliated Hospital of Youjiang Medical University for Nationalities
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jun Liu, MD
Organizational Affiliation
Tianjin Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Zhujiang Hospital
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510285
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Weiyu Han, MD
Phone
13922222718
Email
hanweiyu@live.com
First Name & Middle Initial & Last Name & Degree
Youling Xu, RN
Phone
18210623686
Email
805048508@qq.com
12. IPD Sharing Statement
Citations:
PubMed Identifier
33099502
Citation
Zhu Z, Han W, Lu M, Lin J, Yin Z, Shang X, Weng X, Zha Z, Tian J, Lei G, Hunter DJ, Ding C. Effects of infrapatellar fat pad preservation versus resection on clinical outcomes after total knee arthroplasty in patients with knee osteoarthritis (IPAKA): study protocol for a multicentre, randomised, controlled clinical trial. BMJ Open. 2020 Oct 23;10(10):e043088. doi: 10.1136/bmjopen-2020-043088.
Results Reference
derived
Learn more about this trial
Infrapatellar Fat Pad Preservation Versus Resection on Clinical Outcomes After Total Knee Arthroplasty(IPAKA)
We'll reach out to this number within 24 hrs